Lenvima is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Lenvatinib.
| Product ID | 62856-704_0595269f-a64e-45c8-9490-4cecc2a06227 | 
| NDC | 62856-704 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Lenvima | 
| Generic Name | Lenvatinib | 
| Dosage Form | Capsule | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2018-08-15 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA206947 | 
| Labeler Name | Eisai Inc. | 
| Substance Name | LENVATINIB | 
| Active Ingredient Strength | 4 mg/1 | 
| Pharm Classes | Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2018-08-15 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA206947 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2018-08-15 | 
| Marketing Category | NDA | 
| Application Number | NDA206947 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2018-08-15 | 
| Ingredient | Strength | 
|---|---|
| LENVATINIB | 4 mg/1 | 
| SPL SET ID: | f4bedd21-efde-44c6-9d9c-b48b78d7ed1e | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 62856-704 | Lenvima | Lenvatinib | 
| 62856-708 | Lenvima | Lenvatinib | 
| 62856-710 | Lenvima | Lenvatinib | 
| 62856-712 | Lenvima | Lenvima | 
| 62856-718 | Lenvima | Lenvima | 
| 62856-720 | Lenvima | Lenvima | 
| 62856-724 | Lenvima | Lenvima | 
| 62856-714 | Lenvima | Lenvima | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  LENVIMA  85778136  4744029 Live/Registered | Eisai R&D Management Co., Ltd. 2012-11-13 |